Corporate Sustainability Report

Overview

The report is JB Pharma's maiden sustainability report covering seven manufacturing sites, the Thane R&D office and Mumbai headquarters for April 2021-March 2022. It presents GRI Core disclosures and reports FY2021-22 Scope 1 and Scope 2 emissions of 7638.04 and 8306.99 tCO2e, respectively. Key initiatives include a rooftop solar project, zero-liquid-discharge operations and ETP water recycling. The social section describes a workforce of 4000+ people, while health and safety performance records two fatalities and zero work-related injuries or ill health.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2021-2022
Period: 1 April 2021 – 31 March 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services